These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 21831134

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mesenchymal stem cells induce dendritic cell immune tolerance via paracrine hepatocyte growth factor to alleviate acute lung injury.
    Lu Z, Chang W, Meng S, Xu X, Xie J, Guo F, Yang Y, Qiu H, Liu L.
    Stem Cell Res Ther; 2019 Dec 04; 10(1):372. PubMed ID: 31801626
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hepatocyte growth factor (HGF) and stem cell factor (SCF) maintained the stemness of human bone marrow mesenchymal stem cells (hBMSCs) during long-term expansion by preserving mitochondrial function via the PI3K/AKT, ERK1/2, and STAT3 signaling pathways.
    Cao Z, Xie Y, Yu L, Li Y, Wang Y.
    Stem Cell Res Ther; 2020 Jul 31; 11(1):329. PubMed ID: 32736659
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. HGF/c-Met signalling promotes Notch3 activation and human vascular smooth muscle cell osteogenic differentiation in vitro.
    Liu Y, Wang T, Yan J, Jiagbogu N, Heideman DA, Canfield AE, Alexander MY.
    Atherosclerosis; 2011 Dec 31; 219(2):440-7. PubMed ID: 21920521
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma.
    Standal T, Abildgaard N, Fagerli UM, Stordal B, Hjertner O, Borset M, Sundan A.
    Blood; 2007 Apr 01; 109(7):3024-30. PubMed ID: 17138824
    [Abstract] [Full Text] [Related]

  • 9. Hydroxyapatite Nanoparticles Promote the Development of Bone Microtissues for Accelerated Bone Regeneration by Activating the FAK/Akt Pathway.
    Li L, Li H, Wang Q, Xue Y, Dai Y, Dong Y, Shao M, Lyu F.
    ACS Biomater Sci Eng; 2024 Jul 08; 10(7):4463-4479. PubMed ID: 38848471
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Dose-specific effects of tumor necrosis factor alpha on osteogenic differentiation of mesenchymal stem cells.
    Huang H, Zhao N, Xu X, Xu Y, Li S, Zhang J, Yang P.
    Cell Prolif; 2011 Oct 08; 44(5):420-7. PubMed ID: 21951285
    [Abstract] [Full Text] [Related]

  • 12. Sonic hedgehog enhances the proliferation and osteogenic differentiation of bone marrow-derived mesenchymal stem cells.
    Cai JQ, Huang YZ, Chen XH, Xie HL, Zhu HM, Tang L, Yang ZM, Huang YC, Deng L.
    Cell Biol Int; 2012 Apr 01; 36(4):349-55. PubMed ID: 22149964
    [Abstract] [Full Text] [Related]

  • 13. Decrease of MiR-31 induced by TNF-α inhibitor activates SATB2/RUNX2 pathway and promotes osteogenic differentiation in ethanol-induced osteonecrosis.
    Yu L, Xu Y, Qu H, Yu Y, Li W, Zhao Y, Qiu G.
    J Cell Physiol; 2019 Apr 01; 234(4):4314-4326. PubMed ID: 30132874
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. IGF1 promotes osteogenic differentiation of mesenchymal stem cells derived from rat bone marrow by increasing TAZ expression.
    Xue P, Wu X, Zhou L, Ma H, Wang Y, Liu Y, Ma J, Li Y.
    Biochem Biophys Res Commun; 2013 Apr 05; 433(2):226-31. PubMed ID: 23473758
    [Abstract] [Full Text] [Related]

  • 16. Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation.
    Forte G, Minieri M, Cossa P, Antenucci D, Sala M, Gnocchi V, Fiaccavento R, Carotenuto F, De Vito P, Baldini PM, Prat M, Di Nardo P.
    Stem Cells; 2006 Jan 05; 24(1):23-33. PubMed ID: 16100005
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MiR-375 inhibits the hepatocyte growth factor-elicited migration of mesenchymal stem cells by downregulating Akt signaling.
    He L, Wang X, Kang N, Xu J, Dai N, Xu X, Zhang H.
    Cell Tissue Res; 2018 Apr 05; 372(1):99-114. PubMed ID: 29322249
    [Abstract] [Full Text] [Related]

  • 20. Magnetic Targeting of HU-MSCs in the Treatment of Glucocorticoid-Associated Osteonecrosis of the Femoral Head Through Akt/Bcl2/Bad/Caspase-3 Pathway.
    Duan L, Zuo J, Zhang F, Li B, Xu Z, Zhang H, Yang B, Song W, Jiang J.
    Int J Nanomedicine; 2020 Apr 05; 15():3605-3620. PubMed ID: 32547017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.